Bridging Pediatric to Adult Care: A Scoping Review on Transitional Care for Individuals with Congenital Heart Disease

Salvatore Angileri1, Rocco Mazzotta1, Daniele Ciofi2

  • 1Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy.

Insights

Transitional care for adolescents with congenital heart disease (CHD) needs standardized, evidence-based programs. This review maps literature, identifying key themes like education and structured support for better patient outcomes.

Area of Science:

  • Cardiology
  • Pediatric Healthcare
  • Transition Medicine

Background:

  • Adolescents and young adults with congenital heart disease (CHD) experience significant challenges during the transition from pediatric to adult care.
  • Transitional care is crucial but inconsistently implemented, necessitating a review of existing literature.
  • A systematic mapping of published literature on CHD transitional care is lacking.

Purpose of the Study:

  • To systematically map the literature on transitional care for individuals with congenital heart disease (CHD).
  • To identify key topics and trends in published research on CHD transitional care.
  • To provide a foundation for developing outcome-focused research and individualized transition programs.

Main Methods:

  • A scoping review following Joanna Briggs Institute guidelines.
  • Comprehensive search across seven electronic databases using the Population, Concept, and Context framework.
  • Data analysis using Latent Dirichlet Allocation and Multiple Correspondence Analysis, with lexicometric analysis.

Main Results:

  • Three major themes emerged: Education, Self-Management, and Structured Support; Timing, Knowledge Transfer, and Developmental Needs; and Transition Program Implementation and Coordination.
  • An increasing focus on structured educational strategies, developmentally tailored care, and system-level program delivery was observed.
  • Education-focused interventions were more prevalent in recent, high-quality studies, while implementation and developmental needs were more common in earlier research.

Conclusions:

  • Transitional care for individuals with CHD requires more standardized, evidence-based approaches.
  • Improved documentation in reporting transitional care is essential for enhancing fidelity, scalability, and long-term impact.
  • This review supports the design of individualized, high-quality transition programs focused on outcomes.
Abstract

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...